| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,273 |
31,805 |
$2.00M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,902 |
7,442 |
$665K |
| 99199 |
Unlisted special service, procedure or report |
149,840 |
148,145 |
$548K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,021 |
5,494 |
$520K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,030 |
5,574 |
$510K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
10,056 |
9,120 |
$364K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,165 |
3,906 |
$362K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15,730 |
14,280 |
$308K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,495 |
2,046 |
$282K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
7,458 |
6,984 |
$218K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,544 |
4,209 |
$164K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,203 |
2,858 |
$152K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,436 |
1,336 |
$138K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,314 |
8,520 |
$120K |
| 92587 |
|
9,399 |
8,727 |
$73K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,213 |
7,519 |
$67K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,195 |
2,382 |
$66K |
| 99381 |
|
529 |
508 |
$51K |
| D0145 |
Oral evaluation for a patient under three years of age |
1,465 |
1,371 |
$49K |
| 99463 |
|
567 |
539 |
$48K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,392 |
2,070 |
$43K |
| 99460 |
|
578 |
551 |
$43K |
| 97802 |
|
3,281 |
3,198 |
$40K |
| 90474 |
|
1,186 |
1,105 |
$24K |
| D1206 |
Topical application of fluoride varnish |
1,465 |
1,371 |
$22K |
| 99406 |
|
2,776 |
2,523 |
$21K |
| 99051 |
|
750 |
730 |
$19K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
160 |
150 |
$14K |
| 87634 |
|
374 |
355 |
$11K |
| 90686 |
|
4,727 |
4,314 |
$9K |
| 90671 |
|
84 |
82 |
$7K |
| 90716 |
|
1,346 |
1,204 |
$6K |
| 90734 |
|
300 |
278 |
$5K |
| 90677 |
|
503 |
499 |
$5K |
| 90473 |
|
180 |
170 |
$3K |
| 90651 |
|
228 |
217 |
$3K |
| 81003 |
|
1,430 |
1,359 |
$2K |
| 96127 |
|
504 |
482 |
$2K |
| 87807 |
|
191 |
136 |
$2K |
| 85018 |
|
1,513 |
1,394 |
$2K |
| 96161 |
|
534 |
492 |
$2K |
| 90681 |
|
1,134 |
1,054 |
$1K |
| 90707 |
|
1,337 |
1,193 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
46 |
43 |
$661.20 |
| 90633 |
|
1,573 |
1,425 |
$653.64 |
| 90715 |
|
155 |
139 |
$648.90 |
| 99462 |
|
13 |
12 |
$482.17 |
| 90670 |
|
4,179 |
3,747 |
$464.90 |
| 80061 |
Lipid panel |
14 |
14 |
$243.04 |
| 36416 |
|
2,406 |
2,183 |
$156.06 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
14 |
$142.52 |
| 90672 |
|
199 |
189 |
$118.20 |
| 94760 |
|
146 |
131 |
$24.94 |
| 90700 |
|
86 |
80 |
$0.01 |
| 87999 |
|
159 |
99 |
$0.00 |
| 90380 |
|
13 |
12 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
14 |
14 |
$0.00 |
| 90685 |
|
40 |
38 |
$0.00 |
| 99174 |
|
9,990 |
9,293 |
$0.00 |
| 90647 |
|
2,036 |
1,963 |
$0.00 |
| 90723 |
|
2,156 |
2,065 |
$0.00 |
| 90697 |
|
1,105 |
934 |
$0.00 |
| 90619 |
|
261 |
225 |
$0.00 |
| 90696 |
|
113 |
91 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
14 |
$0.00 |